Analysis
Filter results by
Search HelpKeyword(s)
Subject
Survey or statistical program
Results
All (8)
All (8) ((8 results))
- 1. Canadian biotechnology activity, 2003 ArchivedArticles and reports: 88-003-X20050028021Geography: CanadaDescription:
Between 1997 and 2003, the number of innovative biotechnology firms rose from 282 to 490. Biotechnology in Canada continued to expand between 2001 and 2003, generating revenues of almost $4 billion. Biotechnology companies have more than quadrupled their revenues since 1997, making biotechnology a fast growing activity.
Release date: 2005-06-20 - Articles and reports: 88F0006X2005009Description:
The main indicators of biotechnology activities in Canada are presented in this article. The data are from the 2003 Biotechnology Use and Development Survey. Within the last few years, except for the number of employees with biotechnology-related responsibilities that remained stable, an increase in all the indicators was noticed. For example, the number of innovative firms involved in biotechnology activities rose from 375 in 2001 to 490 in 2003 and biotechnology revenues rose from $3.6 billion to $3.8 billion between 2001 and 2003. Also, biotechnology R&D spending increased by 11% between 2001 and 2003 and the amount of capital raised for biotechnology was up 73% during this period.
Release date: 2005-04-27 - 3. Biotechnology use and development ArchivedArticles and reports: 88-003-X20050017771Geography: CanadaDescription:
Preliminary data indicate the biotechnology sector continued its phenomenal growth in Canada between 2001 and 2003, generating almost $4 billion in revenues. Biotechnology companies have more than quadrupled their revenues since 1997, making biotech a quickly growing activity.
Release date: 2005-02-09 - 4. Factors in biotechnology growth: Results of interviews with leaders of high growth biotechnology firms ArchivedArticles and reports: 88-003-X20040037432Geography: CanadaDescription:
This article is based on a recent series of interviews with leaders of high growth biotechnology firms. It highlights the importance of financing, management strategies and qualified personnel for achieving high growth.
Release date: 2004-10-29 - Articles and reports: 88F0006X2004017Description:
Using data from the 1997 Biotechnology Firm Survey and the 1999 and 2001 cycles of the Biotechnology Use and Development Survey, this article portrays the evolution of key indicators of Canadian biotechnology companies from 1997 to 2001.
Release date: 2004-10-22 - Articles and reports: 88-003-X20040026930Geography: CanadaDescription:
Biotechnology activity in Canada is flourishing. The total number of biotechnology firms has been continually increasing in recent years. This expansion can also be observed from the changes in revenues generated by biotechnology. Research and development (R&D) efforts are starting to bear fruit and this is reflected in the revenue ratio on R&D.
Release date: 2004-06-30 - 7. Strategic alliances in biotechnology: Characteristics and impact on performance indicators ArchivedArticles and reports: 88-003-X20030026571Geography: CanadaDescription:
This article presents the results of a study that looks at the characteristics of Canadian biotechnology firms that form strategic alliances and measures the impact that such alliances have on their performance indicators.
Release date: 2003-06-27 - Articles and reports: 88-003-X20000035770Geography: CanadaDescription:
Given the high cost of R&D, adopting the correct strategies and mix of products is required for success for Canadian biotechnology firms. A recent survey examined the rapid growth of 30 companies. Fast-growing enterprises adopted a strategy of patenting their products, avoiding major production delays, targeting export markets, accessing venture capital, conducting key alliances, and planning the IPO.
Release date: 2000-10-06
Stats in brief (0)
Stats in brief (0) (0 results)
No content available at this time.
Articles and reports (8)
Articles and reports (8) ((8 results))
- 1. Canadian biotechnology activity, 2003 ArchivedArticles and reports: 88-003-X20050028021Geography: CanadaDescription:
Between 1997 and 2003, the number of innovative biotechnology firms rose from 282 to 490. Biotechnology in Canada continued to expand between 2001 and 2003, generating revenues of almost $4 billion. Biotechnology companies have more than quadrupled their revenues since 1997, making biotechnology a fast growing activity.
Release date: 2005-06-20 - Articles and reports: 88F0006X2005009Description:
The main indicators of biotechnology activities in Canada are presented in this article. The data are from the 2003 Biotechnology Use and Development Survey. Within the last few years, except for the number of employees with biotechnology-related responsibilities that remained stable, an increase in all the indicators was noticed. For example, the number of innovative firms involved in biotechnology activities rose from 375 in 2001 to 490 in 2003 and biotechnology revenues rose from $3.6 billion to $3.8 billion between 2001 and 2003. Also, biotechnology R&D spending increased by 11% between 2001 and 2003 and the amount of capital raised for biotechnology was up 73% during this period.
Release date: 2005-04-27 - 3. Biotechnology use and development ArchivedArticles and reports: 88-003-X20050017771Geography: CanadaDescription:
Preliminary data indicate the biotechnology sector continued its phenomenal growth in Canada between 2001 and 2003, generating almost $4 billion in revenues. Biotechnology companies have more than quadrupled their revenues since 1997, making biotech a quickly growing activity.
Release date: 2005-02-09 - 4. Factors in biotechnology growth: Results of interviews with leaders of high growth biotechnology firms ArchivedArticles and reports: 88-003-X20040037432Geography: CanadaDescription:
This article is based on a recent series of interviews with leaders of high growth biotechnology firms. It highlights the importance of financing, management strategies and qualified personnel for achieving high growth.
Release date: 2004-10-29 - Articles and reports: 88F0006X2004017Description:
Using data from the 1997 Biotechnology Firm Survey and the 1999 and 2001 cycles of the Biotechnology Use and Development Survey, this article portrays the evolution of key indicators of Canadian biotechnology companies from 1997 to 2001.
Release date: 2004-10-22 - Articles and reports: 88-003-X20040026930Geography: CanadaDescription:
Biotechnology activity in Canada is flourishing. The total number of biotechnology firms has been continually increasing in recent years. This expansion can also be observed from the changes in revenues generated by biotechnology. Research and development (R&D) efforts are starting to bear fruit and this is reflected in the revenue ratio on R&D.
Release date: 2004-06-30 - 7. Strategic alliances in biotechnology: Characteristics and impact on performance indicators ArchivedArticles and reports: 88-003-X20030026571Geography: CanadaDescription:
This article presents the results of a study that looks at the characteristics of Canadian biotechnology firms that form strategic alliances and measures the impact that such alliances have on their performance indicators.
Release date: 2003-06-27 - Articles and reports: 88-003-X20000035770Geography: CanadaDescription:
Given the high cost of R&D, adopting the correct strategies and mix of products is required for success for Canadian biotechnology firms. A recent survey examined the rapid growth of 30 companies. Fast-growing enterprises adopted a strategy of patenting their products, avoiding major production delays, targeting export markets, accessing venture capital, conducting key alliances, and planning the IPO.
Release date: 2000-10-06
Journals and periodicals (0)
Journals and periodicals (0) (0 results)
No content available at this time.
- Date modified: